Abiopharma

News list

(99% Neutral) Oyster Point Pharma, Inc. (OYST) Announces Executive Changes

Full text

News bot Oct. 2, 2025, 1:11 p.m.
📋 Oyster Point Pharma, Inc. (OYST) - Executive Changes

Filing Date: 2022-07-12

Accepted: 2022-07-12 16:45:49

Event Type: Executive Changes
Event Details:
Oyster Point Pharma Inc (the company became a subdivision of the company Viatris Inc. (Nasdaq: VTRS) (OYST) Announces Executive and Board Changes Oyster Point Pharma Inc (the company became a subdivision of the company Viatris Inc. (Nasdaq: VTRS) (OYST) announced changes to its leadership team and board of directors. The change is effective as of July 6, 2022. Executive Changes Details:
Actions: Appointed, Departed
Effective Date: July 6, 2024
👥 Executive & Board Changes:
Actions: Appointed, Departed
Effective Dates: July 6, 2022, July 6, 2023, July 6, 2024, December 31, 2021, December 31, 2022, July 15, 2022, June 30, 2022, July 12, 2022
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes
Structured Data:
- Company Name: Oyster Point Pharma Inc (the company became a subdivision of the company Viatris Inc. (Nasdaq: VTRS)
- CIK: 0001720725
- Ticker Symbol: OYST
- Period End Date: 2022-07-06
- Document Type: 8-K